Home > Healthcare > Medical Devices > Diagnostic Devices > Urinary Tract Infection Testing Market

Urinary Tract Infection Testing Market Analysis

  • Report ID: GMI5628
  • Published Date: May 2023
  • Report Format: PDF

Urinary Tract Infection Testing Market Analysis

The urinary tract infection testing market is segmented by test type into urinalysis, urine cultures, and susceptibility testing. The urinalysis segment held the largest revenue size over USD 270 million in 2022 and is estimated to reach more than USD 470 million by 2032. The increasing ageing population base is anticipated to cause a growth in the demand for urinalysis during the forecast period. Urinary tract infections are more common in the elderly population.
 

A urine analysis examines the urine sample's chemical, visual, and microscopic components. Healthcare professionals are increasingly using urinalysis to identify urinary tract infections (UTIs), as well as liver, kidney, and diabetic issues. This examination can be carried out to assess UTI symptoms during a standard check-up. Furthermore, an increase in the availability of test types coupled with several other businesses working towards creating innovative technology will support the segment's revenue share.
 

Global Urinary Tract Infection Testing Market Share, By Test Kit Type

UTI testing market is bifurcated based on the test kit type including laboratory test kits and home test kits. The home test kits segment is anticipated to witness highest CAGR at 5.9% during the forecast period owing to better accuracy. UTI home test kits are designed to detect the presence of urinary tract infections (UTIs) in the comfort of own home. These tests typically use a dipstick or strip that is immersed in a urine sample, and the results are available within minutes. Such benefits offered by the home test kits will drive the segment expansion.
 

Urinary tract infection testing market is bifurcated based on the application including urethritis, cystitis, and pyelonephritis. The cystitis segment is anticipated to grow over USD 560 million by 2032. Cystitis is a type of urinary tract infection that affects the bladder. It is a common condition, especially among women. However, if the severity worsens, antibiotics might be required. Within three days of taking antibiotics, patients with uncomplicated cystitis typically show signs of improvement in their symptoms. Some people have frequent cystitis, which may necessitate long-term or continuing medical care. Thus, the aforementioned factors will foster the industry landscape.
 

UTI testing market is segmented by end-use into hospitals, diagnostic laboratories, homecare settings, and others. Hospitals segment dominated the global urinary tract infection testing market accounting for more than 44% business share in 2022 and is estimated to witness significant revenue over USD 450 million by 2032. This is attributable to growing number of people suffering from UTIs across developing countries, rising awareness about urinary tract infection testing, and increasing prevalence of diabetes. Further, increasing disposable spending in developed nations will contribute considerably towards adoption of urinary tract infection testing in homecare settings thereby leading to segment progress.
 

U.S. Urinary Tract Infection Testing Market Size

North America urinary tract infection testing market accounted for more than USD 230 million in 2022 and will grow momentously more than USD 400 million by 2032. The affordability of urinary tract infection testing among the target population base and ongoing technological developments for early detection of UTI are primarily responsible for the regional market growth. Further, the region's high healthcare spending on health care management and rising disposable income will propel the expansion of the North America market. Also, the substantial presence of well-established market participants and the favourable regulatory environment result in a number of product approvals and launches, particularly in the U.S.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for urinary tract infection testing was over USD 590 million in 2022 and will reach over USD 1 billion by 2032.

Hospitals segment will record over USD 450 million by 2032 due to rising cases of UTIs and awareness about UTI testing.

North America UTI testing market size will be more than USD 400 million by 2032 on account of ongoing technological developments for the early detection of UTI.

Thermo Fisher Scientific, Inc., Danaher Corporation, Stryker Corporation, ACON Laboratories Inc., Bio-Rad Laboratories, Cardinal Health Inc., and Abbott Laboratories are the leading providers of urinary tract infection testing.

Urinary Tract Infection Testing Market Scope

Buy Now

Immediate Delivery Available

Premium Report Details

  • Base Year: 2022
  • Companies covered: 11
  • Tables & Figures: 357
  • Countries covered: 32
  • Pages: 200
 Download Free Sample